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Urine epithelial cells underwent the reprogramming procedure
using the CytoTune®-iPS 2.0 Sendai ReprogrammingKit (ThermoFisher
Scientiﬁc, USA) containing reprogramming vectors with the four
Yamanaka factors, Oct3/4, Sox2, Klf4 and c-Myc. These factors have
been repeatedly shown to be sufﬁcient for efﬁcient reprogramming
(Lieu et al., 2013; Takahashi et al., 2007). The identity of derived
human iPS cell line was conﬁrmed by immunocytochemistry, using
the following antibodies for pluripotency markers, TRA-1-60, Sox2,
Oct3/4 and SSEA4 (Fig. 1a). Sendai virus transgenes were undetectable
from passage 7 (Fig. 1c). To conﬁrm trilineage differentiation potential,
in vitro embryonic body (EB) formation assay was performed (Fig. 3a).
Spontaneous differentiation induced the transcription of the following
genes: AFP (endoderm), MSX1 (mesoderm) and Pax6 (ectoderm)
(Fig. 3b). Additionally, the formation of the three germ layers was con-
ﬁrmed at the protein level by immunocytochemistry, which showed the
expression of Nestin, TUJ1, SMA and AFP (Fig. 3c). Ploidy of the derived
iPS cell line was analyzed by low-pass whole-genome sequencing
(Fig. 2) (Wells et al., 2014).
Materials and methods
Derivation of human urine epithelial cell line TOC-4
Procedures for sample collection and iPS cell line generation were
approved by the Institutional Ethics Committee and informed consent
was obtained from the patients and/or their legal tutors. Urine cells
(UCs) were collected and cultured as described previously (Zhou et al.,
2011) with small modiﬁcations. Brieﬂy, fresh urine samples (250–the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of the derived TOC-4 iPS cell line. A) Expression of pluripotency markers: TRA-1-60, SOX2, SSEA4 and OCT3/4. Immunoﬂuorescence staining, red/green:
pluripotency markers, Blue: DAPI, nuclei staining. Scale bars, 200 μm. B) Feeder-free TOC-4 iPS cell line cultures. C) Reverse transcription PCR for the detection of Sendai transgenes
after passage 7. Transduced cell pool at passage 0 was used as positive control. C−, non-template control.
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1700 rpm and washed once with 1xPBS with penicillin/streptomycin
and then plated in 1 mL urine renal epithelial growth medium (REGM,
Lonza, USA) on a gelatin-coated 12-well plate. The cells were expanded
in standard culture conditions (37 °C, 5% CO2) and tested for Mycoplas-
ma (MycoAlert™ PLUS, Lonza, USA) before any further manipulation.
Cells at passage 3 were used for reprogramming.iPS cell line generation and expansion
Cells were reprogrammed using the integration-free CytoTune®-iPS
2.0 Sendai Reprogramming Kit (Thermo Fisher Scientiﬁc, USA), which
contains Sendai virus particles of the four Yamanaka factors (Takahashi
et al., 2007). Brieﬂy, 3.5–4 × 105 urine epithelial cells were plated onto
one well of a gelatin-coated 6-well plate 24 h before viral transduction.
The cells were transduced according to the manufacturer´s protocol.
Four days after transduction, cells were plated onto MEF feeder cells,Fig. 2. Aneuploidy analysis of TOC-4 iPS cell line. Analysis of chromosome copy number was car
View screen depicts overviews of the derived iPS cell line chromosome sets. Dots correspond to
number of bases: 94.8 Mb; total number of bases(AQ20): 83.8 Mb; % bases(AQ20): 88.4; meanand fed with iPS cells' medium supplemented with 30 ng/mL freshly
added bFGF (Thermo Fisher Scientiﬁc, USA). About 7 days after plating,
the ﬁrst appearing colonies were picked for expansion into individual
iPS cell line, transferred onto Matrigel (BD Biosciences, USA)-coated
plates and cultured with E8 medium (Thermo Fisher Scientiﬁc, USA).
After successful adaptation to feeder-free conditions of at least 3 iPS colo-
nies from each patient, the cells were expanded in E8 medium using
0.5 mM EDTA passaging solution (both from Thermo Fisher Scientiﬁc,
USA) (Fig. 1b).Immunoﬂuorescence staining of iPS cells
Oct3/4, Sox2, SSEA4 and Tra-1-60 immunoﬂuorescence staining
conﬁrmed pluripotency gene expression in TOC-4 cell line. iPS colonies
were plated onto 96-well plates (CellCarrier, Perkin-Elmer, USA) and
ﬁxed with 4% paraformaldehyde for 15 min at room temperature.
Fixed cells were permeabilized with 0.3% Triton-X and blocked withried out using low-pass whole genome sequencing. Snapshot of IGV LightWhole Genome
sequencing tiles approximately 2 Mb long each. MAPD: 0.222; read count: 514,581; total
coverage depth(fold): 0.035. MAPD, = median absolute pairwise difference.
Table 1
Reverse transcription-PCR primers.
Target Primer sets Product size
SeV Forward: GGA TCA CTA GGT GAT ATC GAG Ca
Reverse: ACC AGA CAA GAG TTT AAG AGA TAT GTA TCa
181 bp
KOS Forward: ATG CAC CGC TAC GAC GTG AGC GC
Reverse: ACC TTG ACA ATC CTG ATG TGG
528 bp
Klf4 Forward: TTC CTG CAT GCC AGA GGA GCC C
Reverse: AAT GTA TCG AAG GTG CTC AAb
410 bp
c-Myc Forward: TAA CTG ACT AGC AGG CTT GTC Gb
Reverse: TCC ACA TAC AGT CCT GGA TGA TGA TG
532 bp
GAPDH Forward: TTCGACAGTCAGCCGCATC
Reverse: GACTCCACGACGTACTCAGC
352 bp
AFP Forward: AGA GTT GCT AAA GGA TAC CAG GA
Reverse: AGG CCA ATA GTT TGT CCT CAC
301 bp
Pax6 Forward: AGA AAG AGT TTG AGA GAA CCC AT
Reverse: TCA TGT GTG TCT GCA TAT GTG G
468 bp
MSX1 Forward: CCC TGG TGC TGT ACC CC
Reverse: GGT CCC TTC AAC CTA CCT T
547 bp
a Primer contains SeV genome sequences.
b Annealing of these primers to transgene-speciﬁc target sequences but not to endog-
enous genes sequences allows for the speciﬁc detection of the transgenes introduced by
the CytoTune® 2.0 Sendai reprogramming vectors.
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bodies at a 1:100 dilution, at 4 °C, overnight, in a humid chamber. Pri-
mary antibodies were then washed with PBS and cells were incubated
with secondary antibodies at 1:400 dilutions at room temperature for
1 h. After washing and incubation with DAPI for 5 min, cells were
covered with glycerol; the plate was sealed with AlumSeal CS ﬁlm
(Excel Scientiﬁc, USA) and stored at 4 °C until visualization. Images
were acquired using the EVOS XL Cell Imaging System (Thermo Fisher
Scientiﬁc, USA) (Fig. 1a). The antibodies used in the experiments are
listed in Table 2.
In vitro differentiation of TOC iPS cell line
The differentiation ability of TOC-4 iPS cell line was analyzed by in
vitro embryonic body (EB) formation, according to a previously pub-
lished protocol (Itskovitz-Eldor et al., 2000). Brieﬂy, 100mmcell culture
dishes with TOC-4 iPS cells were treated with Collagenase IV (Thermo
Fisher Scientiﬁc, USA) for 30–40 min at 37 °C, washed with PBS and
seeded onto 60 mm culture dishes (Corning, USA). The cultures were
maintained on horizontal shaker in DMEM supplemented with 20%
KSR, non-essential amino acids, L-glutamine, penicillin/streptomycin,
sodium pyruvate (all from Thermo Fisher Scientiﬁc, USA) and without
additional bFGF to allow for formation of embryonic bodies (EBs)
(Fig. 3a). After 7 days, EBswere seeded onto gelatin-coated 100mmcul-
ture dishes and grown for another 21 days withmediumbeing changed
every other day. Subsequently, the cultures were harvested for total
RNA isolation using the GeneJET RNA Puriﬁcation Kit (Thermo Fisher
Scientiﬁc, USA), followed by DNase treatment and reverse transcription
using M-MLV (Thermo Fisher Scientiﬁc, USA). RT-PCR for the three
germ layer markers (Fig. 3b) was carried out using 0.5 μL of the reverse
transcription reaction in a total 10 μL reaction volume, with the follow-
ing parameters: denaturation 95 °C-15 s, Annealing 50 °C-15 s, elonga-
tion 72 °C–1 min (35 cycles). The PCR products were analyzed using
agarose gel (1%) electrophoresis. The primers used for PCR are listed
in Table 1. Part of the cultures was also plated onto 96-well plates
(CellCarrier, Perkin-Elmer, USA) to perform immunocytochemistry forFig. 3. Trilineage differentiation analysis. A) In vitro embryonic body formation assay for pluripot
mesoderm: MSX1; ectoderm: Pax6. C) Immunoﬂuorescence staining detection of germ layer m
germ layer markers. Blue: DAPI (nuclei). Magniﬁcation, 10×.the markers of the three germ layers. Immunostaining was performed
as described above. Images were acquired using the Operetta System
(Perkin-Elmer, USA) (Fig. 3c).
Virus-free status of iPS cells
CytoTune®-iPS 2.0 Reprogramming Kit is considered a non-integra-
tive system. Nevertheless, it is necessary to conﬁrm whether the
derived iPS cells contain any Sendai virus elements after the
reprogramming procedure. To conﬁrm the absence of integration of
Sendai viral vectors, total RNA was isolated from TOC-4 iPS cells using
the GeneJET RNA Puriﬁcation Kit (Thermo Fisher Scientiﬁc, USA). Cells
set-aside at the beginning of the reprogramming procedure (passage
0) were used as positive controls for the presence of Sendai RNA. Theency. B) Conﬁrmation of the expression of germ layermarkers by RT-PCR. Endoderm: AFP;
arkers. Endodermal: AFP, mesodermal: SMA and ectodermal: Nestin and TUJ1. Red/green:
Table 2
Antibodies used for immunocytochemistry.
Antibody Company Catalog number Host Dilution
Sox2 Merck Millipore MAB5603 Rabbit 1:100
Oct3/4 Santa Cruz Biotechnology SC5279 Mouse 1:100
TRA-1-60 Merck Millipore MAB4360 Mouse 1:100
SSEA4 Merck Millipore MAB4304 Mouse 1:100
Nestin Sigma-Aldrich N5413 Rabbit 1:100
TUJ1 Merck Millipore MAB1637 Mouse 1:100
AFP Santa Cruz Biotechnology SC15375 Rabbit 1:100
SMA Sigma-Aldrich A2547 Mouse 1:100
Goat anti-rabbit Alexa Fluor® 488 Thermo Fisher Scientiﬁc A11008 Rabbit 1:400
Goat anti-mouse Alexa Fluor® 594 Thermo Fisher Scientiﬁc A11032 Mouse 1:400
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treated RNA and the M-MLV enzyme (Thermo Fisher Scientiﬁc, USA).
RT-PCRwas carried out using 0.5 μL of the reverse transcription reaction
in a total 10 μL reaction volume, with the following parameters: dena-
turation 95 °C-30 s, annealing 55 °C-30 s, elongation 72 °C-30 s (35 cy-
cles). The PCR products were analyzed using agarose gel (2%)
electrophoresis (Fig. 1c). The primers used for PCR are listed in Table 1.
Aneuploidy analysis of derived iPS cell line
The ploidy of the derived TOC-4 iPS cell line was conﬁrmed by low-
pass whole-genome sequencing (Fig. 2). Genomic DNA was puriﬁed
from approximately 5 × 105 cells using QIAamp DNA Mini Kit (Qiagen,
USA). The sequencing library was constructed by the enzymatic frag-
mentation of 100 ng genomic DNA followed by the ligation of sequenc-
ing adaptors using the Ion Xpress™ Plus Fragment Library Kit (Thermo
Fisher Scientiﬁc, USA). Ligated fragmentswere size selected electropho-
retically using a 2% E-Gel SizeSelect precast agarose gel (Thermo Fisher
Scientiﬁc, USA). Adaptor-mediated ampliﬁcation of the library was sub-
sequently carried out (5 cycles) using the primer mix supplied with the
Ion Xpress™ Plus Fragment Library Kit (Thermo Fisher Scientiﬁc, USA).
The ampliﬁed library was quantitated by real time PCR using the Ion Li-
brary Quantitation Kit, diluted for equalization and 24 pmol were
pooled with other libraries for clonal ampliﬁcation using the Ion
OneTouch system followed by library enrichment performed on the
Ion OneTouch ES (Thermo Fisher Scientiﬁc, USA). Pooled libraries
were sequenced using an Ion 316 Chip on the Ion Personal GenomeMa-
chine using the 200 bp sequencing chemistry Ion PGM™ Hi-Q (Thermo
Fisher Scientiﬁc, USA). Aneuploidy analysis was carried using the Low-
pass whole-genome aneuploidy r. 0 workﬂow of the Ion Reporter
v.5.0 suite. In order to ascertain the accuracy of copy number calling
≥300,000 reads/sample, median absolute pairwise difference (MAPD)≤0.3 and a median coverage depth ≥0.2 were set as minimum
requirements.
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